Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
01/2009
01/01/2009US20090007298 Taxus Transformation Transformed Cells, and Related Compositions and Methods
01/01/2009US20090007297 using nucleotide sequences coding fructosyltransferase for transforming and generating linear or branched polymers of repeating fructose residues with terminal glucose in plant seeds; enhancing animal feeds, medicines and foods
01/01/2009US20090007296 capable of conferring environmental stress tolerance to plants upon over-expression; genetic engineering
01/01/2009US20090007295 Method for Increasing Seed Size
01/01/2009US20090007294 Genetic Engineering of Male Sterility in Plants
01/01/2009US20090007293 Broccoli plants tolerant to hollow/split stem disorder
01/01/2009US20090007292 Corn inbreds like far045 and hybrids thereof
01/01/2009US20090007291 Melon Having High Percent Soluble Solids and Improved Firmness
01/01/2009US20090007290 Soybean variety d4210110
01/01/2009US20090007289 Soybean variety d4523081
01/01/2009US20090007288 Soybean variety d4328762
01/01/2009US20090007287 Soybean variety d4483789
01/01/2009US20090007286 Soybean variety d4311702
01/01/2009US20090007285 Methods for correcting mitotic spindle defects and optimizing preimplantation embryonic developmental rates associated with somatic cell nuclear transfer in animals
01/01/2009US20090007284 Transgenic organism
01/01/2009US20090007283 Transgenic Rodents Selectively Expressing Human B1 Bradykinin Receptor Protein
01/01/2009US20090007282 Centromere, telomere and recognition sequences for recombinase; fragment comprising antibody gene; site-directed recombination detected by green fluorescent protein
01/01/2009US20090007280 Ange gene in atopy
01/01/2009US20090005337 Phosphodiesterases (PDE); used for screening for Cushing's syndrome or bilateral adrenocortical hyperplasia (BAH)
01/01/2009US20090005335 Compounds for the modulation of beta-catenin expression
01/01/2009US20090005334 Nucleic acid derivatives
01/01/2009US20090005332 Compositions and Methods for Modulating Gene Expression Using Self-Protected Oligonucleotides
01/01/2009US20090005330 Methods and Compositions to Inhibit P2x7 Receptor Expression
01/01/2009US20090005313 Activatable clostridial toxins
01/01/2009US20090005311 Expression vector comprising nucleotide sequences coding fructooligosaccharide (FOS)-related protein for enhancing ability of probiotic bacteria to compete in the gastrointestinal tract of mammals
01/01/2009US20090005307 Compositions and Methods for Detection of Colorectal Cancer
01/01/2009US20090005306 Novel Bacillus Thuringiensis Gene with Lepidopteran Activity
01/01/2009US20090005304 Human KCNQ5 potassium channel, methods and compositions thereof
01/01/2009US20090005301 207 Human Secreted Proteins
01/01/2009US20090005299 Method For Producing Carboxy-Terminal-Amidified Peptides
01/01/2009US20090005297 Aprotinin Variants
01/01/2009US20090005296 Ammonium/Ammonia Transporter
01/01/2009US20090005295 Syndecans and angiogenesis
01/01/2009US20090005294 Peptides for the Treatment of Cancer Associated with the Human Papilloma Virus (HPV) and Other Epithelial Tumors
01/01/2009US20090005266 Methods for Making and Using Molecular Switches Involving Circular Permutation
01/01/2009US20090005262 Methods, Compositions and Compound Assays for Inhibiting Amyloid-Beta Protein production
01/01/2009US20090005257 Process for Recovering Polypeptides that Unfold Reversibly from a Polypeptide Repertoire
01/01/2009US20090005253 Double Hybrid System Based on Gene Silencing by Transcriptional Interference
01/01/2009US20090004757 Analyte Assay Using Particulate Labels
01/01/2009US20090004745 P19 Expression Units
01/01/2009US20090004744 Minicells as vaccines
01/01/2009US20090004743 Helper virus-free aav production
01/01/2009US20090004742 Selection of antigen-specific t cells
01/01/2009US20090004741 Biodegradable polyphosphoramidates for controlled release of bioactive substances
01/01/2009US20090004739 Efficient Method of Preparing Dna Inverted Repeat
01/01/2009US20090004735 Promoter and its use
01/01/2009US20090004734 Mutated Anti-CD22 Antibodies With Increased Affinity To CD22-Expressing Leukemia Cells
01/01/2009US20090004733 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides, and uses thereof
01/01/2009US20090004725 Gene coding for protein participating in the addition of mannose phosphate to a sugar chain of a glycoprotein originating in a yeast belonging to the genus Pichia; control of an acidic sugar chain-forming function in the core-like sugar chain of the glycoprotein contained in the yeast
01/01/2009US20090004723 Methods and Compositions Concerning Poxviruses and Cancer
01/01/2009US20090004722 bovine parainfluenza virus (bPIV) cDNA or RNA which may be used to express heterologous gene products; tumor antigens; cancer
01/01/2009US20090004721 genetic construct encoding dengue viral genome comprising full-length genome of dengue virus wherein construct is modified at 13-amino acid encoding region just proximal to pr-M cleavage site so that it is devoid of negatively-charged amino acids and contains additional positively-charged amino acids
01/01/2009US20090004719 Protein-protein interactions in human immunodeficiency virus
01/01/2009US20090004716 Compositions comprising high concentration of biologically active molecules and processes for preparing the same
01/01/2009US20090004705 Using promoter sequences of superoxide dismutase (PSOD) as regulatory tool in expression of heterologous gene sequences in microorganismal hosts
01/01/2009US20090004703 Method for the Production of Suitable Dna Constructs for Specific Inhibition of Gene Expression by Rna Interference
01/01/2009US20090004702 Codon specific mutagenesis
01/01/2009US20090004701 Joining nucleic acid directly to oligonucleotide sequences; obtain oligonucleotide, incubate with primer, ligate, denature, amplify, recover chain extended oligonucleotide
01/01/2009US20090004700 Using indole to suppress cellular activity in transgenic cells, allowing cells to be as bioreactors for extracellular proteins
01/01/2009US20090004696 Stabilized bioactive peptides and methods of identification, synthesis, and use
01/01/2009US20090004695 Microorganisms engineered to express both cytochrome P-450 and the ferredoxin or ferrerdoxin-like protein; hypercholesterolemia and hyperlipidemia; host cells
01/01/2009US20090004694 Sequence of Thermotolerant L-Rhamnose Isomerase Gene and Use of the Same
01/01/2009US20090004693 Production of Polypeptides by Improved Secretion
01/01/2009US20090004676 T1R3 receptor binding assays for identification of taste modulatory compounds
01/01/2009US20090004674 ACPL-related assays
01/01/2009US20090004672 17867, a novel human aminopeptidase
01/01/2009US20090004668 Pre-miRNA loop-modulated target regulation
01/01/2009US20090004664 HCV NS3 replicon shuttle vectors
01/01/2009US20090004657 7B2 Knockout transgenic animals as models of endocrine disease
01/01/2009US20090004656 Thermostable polymerases having altered fidelity and methods of identifying and using same
01/01/2009US20090004653 Sulfonated [8,9]benzophenoxazine dyes and the use of their labelled conjugates
01/01/2009US20090004651 Screening methods for compounds that modulate the activity of G-protein coupled receptors
01/01/2009US20090004650 Methods for detecting a Cyclophilin B SNP associated with Herda
01/01/2009US20090004649 Vector comprising nucleotide sequences coding everninomicin; for introducing heterologous genes into actinomycete chromosome
01/01/2009US20090004645 Methods for Identifying Genes that Mediate a Response of a Living Cell to an Agent
01/01/2009US20090004330 Glycerol-3-Phosphate Dehydrogenase Gene And Use Thereof
01/01/2009US20090004237 B7-Like Molecules and Uses Thereof
01/01/2009US20090004227 Peroral Vaccine Carrier System
01/01/2009US20090004226 Fusion proteins of mycobacterium tuberculosis
01/01/2009US20090004224 Activatable clostridial toxins
01/01/2009US20090004221 Mutant Porcine Reproductive and Respiratory Syndrome Virus
01/01/2009US20090004215 Chimeric G protein based rabies vaccine
01/01/2009US20090004214 Cd4+ Survivin Epitopes and Uses Thereof
01/01/2009US20090004206 Polynucleotides and Polypeptide Sequences Involved in the Process of Bone Remodeling
01/01/2009US20090004205 Prospective identification and characterization of breast cancer stem cells
01/01/2009US20090004203 Methods of treating measles infectious disease in mammals
01/01/2009US20090004198 Human monoclonal antibody binding to human cytomegalovirus and its antigen binding portion
01/01/2009US20090004196 Method of inhibiting osteoclast activity
01/01/2009US20090004194 Tlr agonist (flagellin)/cd40 agonist/antigen protein and dna conjugates and use thereof for inducing synergistic enhancement in immunity
01/01/2009US20090004192 Recombinant anti-epidermal growth factor receptor antibody compositions
01/01/2009US20090004188 antibody that specifically binds to a human TNF Receptor in the BRAIN (TRAIN) polypeptide; useful in regulating cell differentiation, death, and survival
01/01/2009US20090004186 Effector function enhanced recombinant antibody composition
01/01/2009US20090004183 Compositions and Methods for Regulating the Alternative Pathway of Complement
01/01/2009US20090004174 Fusion Proteins
01/01/2009US20090004169 Nucleic Acids For Inhibiting Hairless Protein Expression and Methods of Use Thereof
01/01/2009US20090004163 Method of enhancing proliferation and/or hematopoietic differentiation of stem cells
01/01/2009US20090004158 Methods of controlling proliferation and differentiation of stem and progenitor cells
01/01/2009US20090004156 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha17 GENE
01/01/2009US20090004146 Humanised Baculovirus
01/01/2009US20090004144 Recombinant Adeno-Associated Virus Vector for Treatment of Alzheimer Disease